[ET Net News Agency, 29 December 2021] TIGERMED (03347) fell 1.95% to HK$93.1.
It hits an intra-day low of HK$93.1, hitting a historical low, and an intra-day high of
HK$98. The total shares traded was 142,500, with a value of HK$13.6m. The active buy/sell
ratio is 52:48, with net buying turnover of HK$430,440. CLSA LTD accounts for greatest net
responsive buying turnover of HK$968,870, with volume weighted average price of HK$94.888.
INSTINET PACIFIC accounts for greatest net responsive selling turnover of HK$1.24m, with
volume weighted average price of HK$95.481. The stock has fallen a combined 6.9% over the
past 3 consecutive trading days.
The Hang Seng Index now fell 172 points, or 0.74% to 23,107; the Hang Seng China
Enterprises Index now fell 80 points, or 0.98% to 8,114; the Hang Seng TECH Index now fell
91 points, or 1.65% to 5,477; with an overall turnover of HK$21.57b.
The SSE Composite Index now fell 15 points, or 0.43% to 3,614, with an overall turnover
of RMB170.13b.
The SZSE Component Index now fell 99 points, or 0.67% to 14,737, with an overall
turnover of RMB111.73b.
Basic Information
=================
----------------------------------
Nominal 93.100 % Chg -1.95%
High 98.000 Low 93.100
Shares Tr 142,500 Turnover 13.6m
10-D SMA 103.285 %H.V 67.811
20-D SMA 112.218 VWAP 95.437
50-D SMA 127.817 RSI14 27.189
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 52:48, with net buying turnover
of HK$430,440, falling a combined 6.9% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
TIGERMED (03347) 93.10 -1.95
INNOVENT BIO (01801) 45.90 -0.65
JXR (01951) 8.08 -9.21
WUXI BIO (02269) 85.50 -3.77
BEIGENE (06160) 160.30 +0.25
CANSINOBIO-B (06185) 166.10 -3.88
IMMUNOTECH-B (06978) 16.28 -0.49
AKESO-B (09926) 31.20 +0.48
KINTOR PHARMA-B (09939) 14.02 +4.63
REMEGEN-B (09995) 68.45 -4.73
-----------------------------------------------
(ed)